<div id="readability-page-1"><p>Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) major shareholder Group Gp Lp Column III acquired 5,523 shares of the business's stock in a transaction that occurred on Wednesday, January 14th. The shares were purchased at an average cost of $19.99 per share, for a total transaction of $110,404.77. Following the completion of the transaction, the insider directly owned 999,429 shares in the company, valued at $19,978,585.71. The trade was a 0.56% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.</p><p>Group Gp Lp Column III also recently made the following trade(s): </p><ul><li>On Tuesday, January 13th, Group Gp Lp Column III bought 12,470 shares of Surrozen stock. The stock was purchased at an average cost of $19.80 per share, with a total value of $246,906.00. </li><li>On Tuesday, January 6th, Group Gp Lp Column III bought 15,100 shares of Surrozen stock. The stock was purchased at an average price of $19.89 per share, for a total transaction of $300,339.00. </li><li>On Friday, December 5th, Group Gp Lp Column III purchased 30,884 shares of Surrozen stock. The shares were purchased at an average price of $19.54 per share, for a total transaction of $603,473.36. </li><li>On Thursday, December 4th, Group Gp Lp Column III purchased 5,266 shares of Surrozen stock. The shares were purchased at an average cost of $17.35 per share, with a total value of $91,365.10. </li><li>On Thursday, November 13th, Group Gp Lp Column III acquired 315,457 shares of Surrozen stock. The stock was purchased at an average price of $12.65 per share, with a total value of $3,990,531.05. </li></ul><h2>Surrozen Stock Performance</h2><p>SRZN stock remained flat at $20.00 during midday trading on Thursday. The company had a trading volume of 28,721 shares, compared to its average volume of 83,852. The business has a 50 day simple moving average of $18.38 and a 200-day simple moving average of $13.80. Surrozen, Inc. has a fifty-two week low of $5.90 and a fifty-two week high of $24.94. The stock has a market capitalization of $171.40 million, a P/E ratio of -0.90 and a beta of 0.58. </p><p>Surrozen (NASDAQ:SRZN - Get Free Report) last posted its earnings results on Friday, November 7th. The company reported ($3.61) EPS for the quarter, missing analysts' consensus estimates of ($1.17) by ($2.44). The business had revenue of $0.98 million during the quarter. Surrozen had a negative return on equity of 4,055.04% and a negative net margin of 2,909.10%. On average, equities analysts predict that  Surrozen, Inc. will post -8.49 earnings per share for the current year. </p><h2>Analysts Set New Price Targets</h2><p>Several research firms have issued reports on SRZN. Lifesci Capital upgraded shares of Surrozen to a &#34;strong-buy&#34; rating in a research note on Thursday, November 13th. Weiss Ratings  reissued a &#34;sell (d-)&#34; rating on shares of Surrozen in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Surrozen to a &#34;sell&#34; rating in a research report on Friday, November 28th. One investment analyst  has rated the stock with a Strong Buy rating, one  has issued  a Buy rating and one  has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $32.00.</p><p><b>View Our Latest Analysis on SRZN</b></p><h2>Institutional Investors Weigh In On Surrozen</h2><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. Braidwell LP bought a new position in shares of  Surrozen in the 2nd quarter worth approximately $1,252,000.  Stempoint Capital LP increased its holdings in  Surrozen by 185.1% during the second quarter. Stempoint Capital LP now owns 686,539 shares of the company's stock valued at $6,138,000 after buying an additional 445,713 shares during the last quarter.  Stonepine Capital Management LLC increased its holdings in  Surrozen by 7.1% during the second quarter. Stonepine Capital Management LLC now owns 306,029 shares of the company's stock valued at $2,736,000 after buying an additional 20,247 shares during the last quarter.  Vanguard Group Inc. raised its position in  Surrozen by 21.7% in the third quarter. Vanguard Group Inc. now owns 266,418 shares of the company's stock worth $3,433,000 after acquiring an additional 47,468 shares during the period.  Finally, Acuta Capital Partners LLC boosted its stake in shares of  Surrozen by 5.0% during the 3rd quarter. Acuta Capital Partners LLC now owns 178,415 shares of the company's stock worth $2,299,000 after acquiring an additional 8,415 shares during the last quarter. Hedge funds and other institutional investors own  66.57% of the company's stock. </p><h2>Surrozen Company Profile</h2> (Get Free Report)<p>Surrozen, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutic antibodies that target the Wnt signaling pathway for applications in tissue repair, regeneration and oncology. Founded in 2012 and headquartered in South San Francisco, California, the company leverages its proprietary SurroBody platform to design bispecific antibody molecules capable of modulating Wnt receptor activity with enhanced tissue specificity.  </p><p>The SurroBody platform enables the generation of high-affinity, dual-binding antibodies engineered to either activate or inhibit Wnt signaling, a pathway critical to cell proliferation, differentiation and homeostasis.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Surrozen</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>Executive Order 14330: Trump’s Biggest Yet</li><li>The Crash Has Already Started (Most Just Don’t See It Yet)</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JaTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JaTg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Surrozen Right Now?</h2><p>Before you consider Surrozen, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surrozen wasn't on the list.</p><p>While Surrozen currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SRZN

<p>Surrozen, Inc. (NASDAQ:SRZN) major shareholder Group Gp Lp Column III purchased 5,523 shares at $19.99 each, totaling $110,404.77, increasing their stake by 0.56%. Post-transaction, they own 999,429 shares valued at approximately $19.98 million. This transaction was disclosed to the SEC. Recent trades by the same shareholder include purchases of 12,470 shares at $19.80, 15,100 shares at $19.89, and 30,884 shares at $19.54. SRZN stock remained flat at $20.00, with a market cap of $171.40 million and a P/E ratio of -0.90. Analysts have mixed ratings on the stock, with a consensus price target of $32.00.</p>

Surrozen (NASDAQ:SRZN) Major Shareholder Buys $110,404.77 in Stock